BMD4503-1
BMD4503-1 is a quinoxaline derivative. BMD4503-1 can inhibit the LRP5/6-Sclerostin interaction and regulate the Wnt signaling pathway[1].
Product Specifications
CAS Number
[301357-76-6]
UNSPSC
12352005
Target
Wnt
Related Pathways
Stem Cell/Wnt
Field of Research
Others
Smiles
O=C(C)NC1=CC=C(S(=O)(NC2=NC3=C(N=C2NC4=CC=CC=C4)C=CC=C3)=O)C=C1
Molecular Formula
C22H19N5O3S
Molecular Weight
433.48
References & Citations
[1]Choi J, et al. In silico discovery of quinoxaline derivatives as novel LRP5/6-sclerostin interaction inhibitors. Bioorg Med Chem Lett. 2018 Apr 1;28 (6) :1116-1121.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
246644-ML490 100 µL
GLRX5 (Glutaredoxin 5, C14orf87, FLB4739, GRX5, MGC14129, PR01238, PRO1238) (MaxLight 490)
Ask
View Details 
